Upload Avatar (500 x 500)
Shandong Ye
ysd196406@163.com
Chinese, English
Anhui
University of Science and Technology of China
Mayo Clinic College of Medicine
  • 1993.07–1995.12 Doctorate: Shanghai Medical University, Endocrinology
  • 1990.09–1993.07 Master's: Shanghai Medical University, Endocrinology
  • 1982.09–1987.07 Bachelor's: Wannan Medical College, Clinical Medicine
  • Achievement: Hosted Anhui Provincial Natural Science Second Prize once
  • Achievement: Anhui Provincial Science and Technology Progress Second Prize twice
  • Achievement: First Jianghuai Famous Doctor, enjoys special government allowance from the State Council
  • 2017.12-present - University of Science and Technology of China, First Affiliated Hospital, Endocrinology Department, Professor
  • 2002.7-2017.12 - Anhui Provincial Hospital, Endocrinology Department, Professor
  • 2002.7-2017.12 - Anhui Provincial Hospital, Endocrinology Department, Chief Physician
  • 1997.7-2002.12 - Anhui Provincial Hospital, Endocrinology Department, Associate Professor
  • 1997.7-2002.12 - Anhui Provincial Hospital, Endocrinology Department, Associate Chief Physician
  • 1995.12-1997.12 - Anhui Provincial Hospital, Internal Medicine, Attending Physician
  • Anhui Provincial Natural Science Second Prize: Hosted once
  • Anhui Provincial Science and Technology Progress Second Prize: Twice
  • First Jianghuai Famous Doctor: Enjoys special government allowance from the State Council
Early diagnosis, intervention, and pathogenesis of chronic complications of diabetes
Basic and clinical research on intensive insulin therapy for type 2 diabetes
  • Saxagliptin attenuates glomerular podocyte injury by increasing the expression of renal nephrin and podocin in type 2 diabetic rats., Hu Y, Ye* S, Xing Y, Lv L, Hu W, Zhou W, 2020
  • Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia., Zhou W, Ye* S, Wang W, Li S, Hu Q, 2020
  • Metformin inhibits high glucose-induced mesangial cell proliferation, inflammation and ECM expression through the SIRT1-FOXO1-autophagy axis., Xu J, Chen Y, Xing Y, Ye * S, 2019
  • Silibinin ameliorates diabetic nephropathy via improving diabetic condition in the mice., Liu Y, Ye J, Cao Y, Zhang R, Wang Y, Zhang S, Dai W, Ye *S, 2019
  • MiR-181c restrains nitration stress of endothelial cells in diabetic db/db mice through inhibiting the expression of FoxO1., Guangwei Yang; Yuanbo Wu; Shandong Ye*, 2017
  • A study of urinary Tamm-Horsfall protein excretion in adult type 2 diabetes mellitus., Zheng M, Ye S, Chen Y, Chen M, 2018
  • Involvement of RBP4 in Diabetic Atherosclerosis and the Role of Vitamin D Intervention., Zhou W, Ye SD, Chen C, Wang W, 2018
  • Metformin ameliorates podocyte damage by restoring renal tissue nephrin expression in type 2 diabetic rats., Zhai L, Gu J, Yang D, Hu W, Wang W, Ye S, 2017
Diabetes Chronic Complications Early Diagnosis Intervention Pathogenesis Insulin Therapy Type 2 Diabetes Clinical Research Basic Research Endocrinology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.